Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|March 26, 2026
Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World ExperienceDerya Koyun, Uğur Şahin, Güldane Cengiz Seval, et al.American Journal of Hematology|January 10, 2023
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSebastian Giebel, Myriam Labopin, Thomas Schroeder, et al.Transplantation and Cellular Therapy|April 8, 2021
Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic LeukemiaBhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, et al.Hemasphere|October 19, 2022
Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.Haematologica|May 2, 2020
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemiaArnon Nagler, Abraham S Kanate, Myriam Labopin, et al.Bone Marrow Transplantation|February 8, 2019
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapiesJakob R Passweg, Helen Baldomero, Grzegorz W Basak, et al.Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|November 9, 2002
Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yieldTaner Demirer, Osman Ilhan, Meltem Ayli, et al.Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.Cancer|September 16, 2022
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMTArnon Nagler, Myriam Labopin, Mutlu Arat, et al.Bone Marrow Transplantation|May 13, 2022
Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMTIvetta Danylesko, Christophe Peczynski, Myriam Labopin, et al.Pageof 12